Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis
Brain and Spine · 2025 · 5 · 105867
DOI: 10.1016/j.bas.2025.105867 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Spine, 2025. Verfasst von Wietse Geens und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, UZ Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Extent of resection (EOR) is a well-known prognostic factor in patients with newly diagnosed IDH-wildtype glioblastoma. However, reported survival times across resection categories vary between reports, and outcomes of submaximal or supramaximal resection remain less well defined.
Methods
We conducted a systematic review and meta-analysis on the association between EOR and overall survival (OS) in patients with newly diagnosed IDH-wildtype glioblastoma treated with chemoradiotherapy. Studies were included if OS was reported by EOR category. Risk ratios (RRs) for 1- and 2-year survival were pooled using a random-effects model. Study quality was assessed using the Newcastle-Ottawa Scale.
Results
Thirty-one studies involving 26,167 patients were included. Supramaximal resection (SupraMR) was associated with significantly improved 2-year survival compared to maximal CE resection (MR) (RR 0.70, 95 % CI 0.55-0.88). Compared to submaximal resection (subMR), MR was associated with higher 1-year survival (RR 0.59, 95 % CI 0.53-0.67) and 2-year survival (RR 0.82, 95 % CI 0.77-0.87). Biopsy alone was associated with the poorest outcome. Findings remained robust in sensitivity analyses excluding SEER and RTOG cohorts.
Conclusions
Increasing EOR seems to be associated with improved survival in newly diagnosed IDH-wildtype glioblastoma. SupraMR offers the greatest benefit, while submaximal resection appears to be more favorable than biopsy. These findings support the prognostic relevance of EOR and underscore the need for prospective studies with standardized resection classifications. The balanced summary of survival data for each resection class provided in this review can serve as a basis for effect estimation and sample size calculations in future trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, UZ Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
- Vrije Universiteit Brussel, Faculty of Medicine, Laarbeeklaan 103, 1090, Brussels, Belgium.
- Department of Medical Oncology, UZ Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium.
Zitieren
APA
Geens, W., Rizani, G., Del Gaudio, N., Buyck, F., Van Gestel, F., Bruneau, M., Neyns, B., & Duerinck, J. (2025). Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis. Brain and Spine, 5, 105867. https://doi.org/10.1016/j.bas.2025.105867
Vancouver
Geens W, Rizani G, Del Gaudio N, Buyck F, Van Gestel F, Bruneau M, et al. Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis. Brain and Spine. 2025;5:105867. doi:10.1016/j.bas.2025.105867
BibTeX
@article{Geens2025,
author = {Geens, Wietse and Rizani, Gzim and Del Gaudio, Nicole and Buyck, Félix and Van Gestel, Frederick and Bruneau, Michaël and Neyns, Bart and Duerinck, Johnny},
title = {Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis},
journal = {Brain and Spine},
year = {2025},
volume = {5},
pages = {105867},
doi = {10.1016/j.bas.2025.105867}
}
EUVIMED